| |
| September 24, 2007 |
FDA Consultant to Help Guide Sernova Through Regulatory Approval Process |
| September 10, 2007 |
Sertoli Cells Successfully Engineered to Secrete Insulin and are Effective in Preclinical Models of Diabetes |
| July 30, 2007 |
Sernova Files Worldwide Patent Application for Innovative Component of Diabetes |
| May 09, 2007 |
Sernova Raises $2.4 Million to Advance Sertolin to Clinical Trails |
| May 03, 2007 |
Sernova Directors and Management Established for 2007/2008 -- Dr. George Adams Named Chair; Justin Leushner Becomes CEO |
| April 16, 2007 |
Journal of Clinical Immunology: Sertoli Cells Could Replace Immunosuppressive Drugs in Humans |
| April 02, 2007 |
Sernova Corp. Information To Be Available Through S&P Market Access Program |
| February 05, 2007 |
Pre-Clinical Milestones for Sertolin Cell Replacement Technology: Insulin-Producing Cells Survive and Function without Anti-Rejection Drugs |
| January 08, 2007 |
Award Winning Harvard Diabetes Specialist Appointed to Help Advance Sernova's Sertolin Diabetes Therapy to Clinical Trials |
| December 19, 2006 |
Results of Toronto Hospital Study of Diabetic Mice Supports Sernova Corp's Cellular Therapy Technology |
| |
